# Validation Study of Frontier X Plus (FX+) Device

> **NCT06471764** · — · NOT_YET_RECRUITING · sponsor: **Fourth Frontier Technologies Pvt Ltd.** · enrollment: 125 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** FX+ and 12-Lead ECG Recording

## Key facts

- **NCT ID:** NCT06471764
- **Lead sponsor:** Fourth Frontier Technologies Pvt Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-01-20
- **Final completion:** 2025-04-20
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2024-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06471764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06471764, "Validation Study of Frontier X Plus (FX+) Device". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06471764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*